Digital speech markers for monitoring ALS in Spanish speakers
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial uses smartphone recordings of your voice to track changes in ALS over time. It aims to find digital markers that can help monitor the disease, which may lead to better care for Spanish-speaking patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with definite ALS.
- You speak Spanish as your first language or are a monolingual Spanish speaker.
- You can read and write in Spanish.
- You have a speech score of 2 or higher on the ALS Functional Rating Scale (meaning you can still speak, even if it's not perfect).
- You do not have other serious lung diseases like COPD or emphysema, and you do not currently smoke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses smartphone apps and digital tools to track physical changes in people with ALS. It aims to better understand how the disease affects daily function, which could help improve future care.
This study looks at how people with ALS and their conversation partners talk with each other. It aims to understand changes in speech and find better ways to support communication.
This study uses a wearable device to track movement patterns in people with ALS. It aims to better understand how the disease affects movement over time, which may help improve care.
This study continuously measures activity and movement in people with ALS and in control participants. It aims to better understand how muscle disease changes day-to-day function, which may help improve future monitoring or care.
This study follows people with ALS and healthy volunteers over time to understand the disease better. You can join from home using a smartphone or computer.
This study follows people with ALS and healthy volunteers to measure how specific body fluids, symptoms, and at-home tracking change over time. It may help researchers find early signs of disease changes and better ways to measure treatment effects.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.